Siyan Liao

发表

Anti-rheumatic agent auranofin induced apoptosis in chronic myeloid leukemia cells resistant to imatinib through both Bcr/Abl-dependent and -independent mechanisms

Quentin Liu, D. Zang, Jinbao Liu, 2014, Oncotarget.

Gambogic Acid Induces Apoptosis in Imatinib-Resistant Chronic Myeloid Leukemia Cells via Inducing Proteasome Inhibition and Caspase-Dependent Bcr-Abl Downregulation

Q. Dou, Jinbao Liu, P. Zhou, 2013, Clinical Cancer Research.

Bilirubin neurotoxicity is associated with proteasome inhibition

Jinbao Liu, Y. Nie, P. Zhou, 2017, Cell Death & Disease.

Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth

Ping Zhou, Wenbin Song, Li Xu, 2014, Oncotarget.

L-Carnitine Is an Endogenous HDAC Inhibitor Selectively Inhibiting Cancer Cell Growth In Vivo and In Vitro

Bing Li, Wenbin Song, Li Xu, 2012, PloS one.

A novel nickel complex works as a proteasomal deubiquitinase inhibitor for cancer therapy

D. Zang, Q. Dou, Jinbao Liu, 2016, Oncogene.

Gambogic acid is a tissue-specific proteasome inhibitor in vitro and in vivo.

Q. Dou, Jinbao Liu, P. Zhou, 2013, Cell reports.

A Ruthenium(II) complex as a potential luminescent switch-on probe for G-quadruplex DNA

Wenjie Mei, S. Liao, Qiong Wu, 2017 .

3‐O‐(Z)‐coumaroyloleanolic acid overcomes Cks1b‐induced chemoresistance in lung cancer by inhibiting Hsp90 and MEK pathways

Yongmei Li, Jingqi Chen, S. Liao, 2017, Biochemical pharmacology.

Synthesis, DNA-binding Properties and Quantitative Structure-Activity Relationships on Ruthenium(II) Complexes with Calf-Thymus DNA

Fan Yang, Wenjie Mei, S. Liao, 2016 .

Probing biased activation of mu-opioid receptor by the biased agonist PZM21 using all atom molecular dynamics simulation.

K. Tan, Chun Wu, S. Liao, 2021, Life sciences.

Platinum-containing compound platinum pyrithione is stronger and safer than cisplatin in cancer therapy

D. Zang, Jinbao Liu, Zhiming He, 2016, Biochemical pharmacology.

Cadmium pyrithione suppresses tumor growth in vitro and in vivo through inhibition of proteasomal deubiquitinase

Xiaolan Zhang, Jinbao Liu, Zhiming He, 2018, BioMetals.

Identification of HPCAL1 as a specific autophagy receptor involved in ferroptosis

D. Klionsky, G. Kroemer, Jinbao Liu, 2022, Autophagy.

To Probe Full and Partial Activation of Human Peroxisome Proliferator-Activated Receptors by Pan-Agonist Chiglitazar Using Molecular Dynamics Simulations

Chun Wu, Holli-Joi Sullivan, S. Liao, 2020, PPAR research.

HDAC Inhibitor L-Carnitine and Proteasome Inhibitor Bortezomib Synergistically Exert Anti-Tumor Activity In Vitro and In Vivo

B. Li, Q. Dou, Jinbao Liu, 2012, PloS one.

Repurposing an antidandruff agent to treating cancer: zinc pyrithione inhibits tumor growth via targeting proteasome-associated deubiquitinases

D. Zang, Jinbao Liu, Xiaofen Li, 2017, Oncotarget.

Chiral Ru(ii) complexes act as a potential non-viral gene carrier for directional transportation to the nucleus and cytoplasm.

Wen-jie Zheng, Wenjie Mei, S. Liao, 2020, Metallomics : integrated biometal science.

High-order self-assembly of G-quadruplex DNA: Nano-network formation under the guidance of arene ruthenium(II) complexes.

Jian Wu, Wenjie Mei, S. Liao, 2018, Journal of inorganic biochemistry.

Microwave-assisted synthesis of arene ruthenium(II) complexes [(η⁶-RC₆H₅)Ru(m-MOPIP)Cl]Cl (R = -H and -CH₃) as groove binder to c-myc G4 DNA.

Wen-jie Zheng, Tianfeng Chen, Jian Wu, 2014, Dalton transactions.

Binding of agonist WAY-267,464 and antagonist WAY-methylated to oxytocin receptor probed by all-atom molecular dynamics simulations.

Chun Wu, Haiguang Liu, A. Uba, 2020, Life sciences.

Analysis of vismodegib resistance in D473G and W535L mutants of SMO receptor and design of novel drug derivatives using molecular dynamics simulations.

Chun Wu, S. Liao, Cecilia Floyd, 2020, Life sciences.

Interaction analyses of hTAAR1 and mTAAR1 with antagonist EPPTB.

Chun Wu, M. Pino, C. Deleon, 2022, Life sciences.

Piperlongumine overcomes imatinib resistance by inducing proteasome inhibition in chronic myelogenous leukemia cells.

Jinbao Liu, S. Liao, Xin Chen, 2022, Journal of ethnopharmacology.